Mei S, Huang J, Zhang Z, Lei H, Huang Q, Qu L
Int J Mol Sci. 2025; 26(5).
PMID: 40076844
PMC: 11900204.
DOI: 10.3390/ijms26052208.
Zhang J, Wei X, Xie Y, Peng S, Yang P, Chen Y
Oncogene. 2025; .
PMID: 40044982
DOI: 10.1038/s41388-025-03323-1.
Zhao Y, Zhang Z, Zheng Y, Bai H, Wu X, Yang Y
J Cancer Res Clin Oncol. 2025; 151(3):98.
PMID: 40035871
PMC: 11880183.
DOI: 10.1007/s00432-025-06153-6.
Chen Y, Shi H, Dong Y, Cui W
Discov Oncol. 2025; 16(1):150.
PMID: 39928213
PMC: 11811353.
DOI: 10.1007/s12672-025-01920-w.
Sun G, He L
Front Immunol. 2025; 15:1498781.
PMID: 39916954
PMC: 11798941.
DOI: 10.3389/fimmu.2024.1498781.
Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy.
Pei D, Zhang D, Guo Y, Chang H, Cui H
Int J Mol Sci. 2025; 26(2).
PMID: 39859408
PMC: 11766336.
DOI: 10.3390/ijms26020694.
Systematic identification of pathological mechanisms, prognostic biomarkers and therapeutic targets by integrating lncRNA expression variation in salivary gland mucoepidermoid carcinoma.
Zou Y, Shan X, Qiu J, Geng Y, Xie S, Xiang R
Sci Rep. 2025; 15(1):1573.
PMID: 39794354
PMC: 11724123.
DOI: 10.1038/s41598-025-85535-9.
Copper metabolism-related lncRNAs predict prognosis and immune landscape in liver cancer patients.
Luo R, Huang S, Shi X, Xu H, Peng J, Lei W
Transl Cancer Res. 2024; 13(11):5784-5800.
PMID: 39697711
PMC: 11651766.
DOI: 10.21037/tcr-24-611.
The roles of LncRNA CARMN in cancers: biomarker potential, therapeutic targeting, and immune response.
Liu H, Liu X, Lu Y
Discov Oncol. 2024; 15(1):776.
PMID: 39692999
PMC: 11655820.
DOI: 10.1007/s12672-024-01679-6.
Innovation in CRC Research: Targeting SPACA6P-AS for Progression.
Ma T, Jin Y, Wang S, Hu H, Wang M, Yan G
J Biochem Mol Toxicol. 2024; 38(12):e70039.
PMID: 39655708
PMC: 11629451.
DOI: 10.1002/jbt.70039.
Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer.
Zhu Z, Xuan W, Wang C, Li C
Front Oncol. 2024; 14:1481777.
PMID: 39655078
PMC: 11625809.
DOI: 10.3389/fonc.2024.1481777.
High-Throughput Single-Nucleus RNA Profiling of Minimal Puncture FFPE Samples Reveals Spatiotemporal Heterogeneity of Cancer.
Jiang W, Zhang X, Xu Z, Cheng Q, Li X, Zhu Y
Adv Sci (Weinh). 2024; 12(4):e2410713.
PMID: 39630113
PMC: 11789576.
DOI: 10.1002/advs.202410713.
Deciphering the role of NcRNAs in Pancreatic Cancer immune evasion and drug resistance: a new perspective for targeted therapy.
Gong Y, Gong D, Liu S, Gong X, Xiong J, Zhang J
Front Immunol. 2024; 15:1480572.
PMID: 39555076
PMC: 11563824.
DOI: 10.3389/fimmu.2024.1480572.
New sights on long non-coding RNAs in glioblastoma: A review of molecular mechanism.
Bagheri-Mohammadi S, Karamivandishi A, Mahdavi S, Siahposht-Khachaki A
Heliyon. 2024; 10(21):e39744.
PMID: 39553554
PMC: 11564028.
DOI: 10.1016/j.heliyon.2024.e39744.
Roles and Applications of Circulating Tumor-Derived RNAs in Sarcoma Patients: A Systematic Review.
Gabrielli E, Bocchi M, Giuli C, Farine F, Costa D, Maccauro G
Int J Mol Sci. 2024; 25(21).
PMID: 39519267
PMC: 11546317.
DOI: 10.3390/ijms252111715.
Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma.
Chen J, Gao Y, Zhong J, Wu X, Leng Z, Liu M
Cell Rep Med. 2024; 5(11):101806.
PMID: 39481387
PMC: 11604490.
DOI: 10.1016/j.xcrm.2024.101806.
LINC00161 upregulated by M2-like tumor-associated macrophages promotes hepatocellular carcinoma progression by methylating HACE1 promoters.
Zhang Y, Chen S, You L, He Z, Xu P, Huang W
Cytotechnology. 2024; 76(6):777-793.
PMID: 39435425
PMC: 11490593.
DOI: 10.1007/s10616-024-00653-y.
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics.
Pinkney H, Ross C, Hodgson T, Pattison S, Diermeier S
NPJ Precis Oncol. 2024; 8(1):230.
PMID: 39390212
PMC: 11467462.
DOI: 10.1038/s41698-024-00728-1.
Combination of circulating tumor cells, lncRNAs and DNA methylation for the diagnosis of endometrial carcinoma.
Ding H, Wang J, Zhao X, Xiu S, Cai H, Ma J
Oncol Lett. 2024; 28(5):545.
PMID: 39310026
PMC: 11413727.
DOI: 10.3892/ol.2024.14678.
Immune-Related Long Non-Coding RNA Signature Determines Prognosis and Immunotherapeutic Coherence in Esophageal Cancer.
Uttam V, Kapoor H, Rana M, Yadav R, Prakash H, Jain M
Cancer Inform. 2024; 23:11769351241276757.
PMID: 39282627
PMC: 11401149.
DOI: 10.1177/11769351241276757.